The synthesis and biological assessment of 2,5-disubstituted-1,3,4-oxadiazoles derivatives from amino acids as new potential antibacterial and antioxidant agents have been reported. The structures of the new synthesized compounds were characterized based on physicochemical and spectral data UV–Visible, IR, 1HNMR, 13CNMR. All the target compounds were screened for theirin vitroantibacterial activityagainst three Gram-positivebacterial strains,namely Staphylococcus aureus ATCC 25923, Bacillus cereus ATCC 14579, Listeria innocua ATCC 33090, and two Gram-negative bacterial strains,namely Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 25922, andantifungal activityagainst Candida albicans ATCC 10231 in comparison with Amoxicillin, Tetracycline, Gentamicin and Oxacillin. The only compound 1-{(4S)-4-amino-4-[5-(2-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]butyl}guanidine 5e with the amine radical thatshowed excellent results against all bacteria, particularly against L. innocua (IZ = 12 mm), has excellent antifungal activity (IZ = 32 mm). The compounds 2-[5-(1-amino-3-methylbutyl)-1,3,4-oxadiazol-2-yl]phenol 5b and 2-[5-(pyrrolidin-2-yl)-1,3,4-oxadiazol-2-yl]phenol 5j have excellent activities (IZ = 27 and IZ = 28 mm, respectively) against B. cereus and P. aeruginosa. Compounds 2-{5-[(1R)-1-amino-2-sulfanylethyl]-1,3,4-oxadiazol-2-yl}phenol 5c, 2-{5-[(1S)-1-amino-3-(methylsulfanyl)propyl]-1,3,4-oxadiazol-2-yl}phenol 5dwith the sulfur radical, 3--[5-(2-3-amino hydroxyphenyl)-1,3,4-oxadiazol-2-yl]propanamide 5g with the amide radical, 5j with the amino radical, and 4-amino-4-[5-(2-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]butanoic acid 5k gave good results against B. cereus, where 19 mm < IZ < 23 mm. We also found that compound 5j has the greatest activity (IZ = 33 mm) against C. albicans, followed by compounds 5e (IZ = 32 mm) and 5b (IZ = 30 mm). The synthesized compounds were also screened for radical scavenging antioxidant activities by DPPH, FRAP, and TAC assays and found to be good antioxidant agents. According to the IC50 values, all compounds demonstrated good to excellent activity, especially 5b and 2-{5-[1-amino-2-(1H-imidazol-4-yl)ethyl]-1,3,4-oxadiazol-2-yl}phenol 5i for DPPH, 5e and 5i for FRAP and methyl 2-hydroxybenzoate 2,2-{5-[1-amino-2-(1H-indol-3-yl)ethyl]-1,3,4-oxadiazol-2-yl}phenol 5h with the imidazol group and 2-[5-(1,5-diaminopentyl)-1,3,4-oxadiazol-2-yl]phenol 5f with the imidazol group for TAC. All these compounds showed better activity than AA and BHT.
Read full abstract